Literature DB >> 7643914

Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites.

G J Molderings1, M Göthert.   

Abstract

The involvement of imidazoline receptors in modulation of noradrenaline release was investigated in the rabbit aorta preincubated with [3H]noradrenaline and superfused with physiological salt solution containing cocaine, corticosterone and propranolol. After blockade of alpha 2-autoreceptors by rauwolscine, the electrically evoked tritium overflow was inhibited by various imidazolines and guanidines. The rank order of potency was BDF 7579 (4-chloro-2-isoindolinyl) guanidine) > or = BDF 6143 (4-chloro-2-(2-imidazolin-2-ylamino)-isoindoline) > BDF 6100 [2-(2-imidazolin-2-ylamino)-isoindoline] > clonidine > ST587 (2-(2-chloro-5-trifluoromethylphenylimino) imidazolidine nitrate) > or = cirazoline > tolazoline > idazoxan > phentolamine. Comparison of the potencies of these drugs with those previously found for the presynaptic imidazoline receptors in the rabbit pulmonary artery revealed a very good correlation. In contrast, no positive correlation was found with their affinities for the I1- and I2-imidazoline binding sites in bovine adrenal medullary membranes and with their lipophilicity (log P values). The electrically evoked tritium overflow was also inhibited by the recently identified endogenous imidazoline receptor ligand agmatine, but was not affected by amiloride. In further series of experiments, the ability of putative antagonist at presynaptic imidazoline receptors to counteract the inhibitory effect of imidazoline derivatives was determined. Amiloride, imidazole-4-acetic acid and 1-benzylimidazole did not attenuate the inhibitory effect of BDF 6143 on the electrically evoked tritium overflow. In contrast, rauwolscine antagonized the inhibitory effect of various imidazolines; rauwolscine was clearly less potent in antagonizing the effect of clonidine, BDF 6143 and cirazoline (apparent pA2 6.48-7.32) than in antagonizing that of oxymetazoline and moxonidine (apparent pA2 8.33 and 8.12, respectively). In a final series of experiments, BDF 6143 (under the conditions applied a selective agonist at presynaptic imidazoline receptors) proved to be considerably less potent in inhibiting tritium overflow evoked by high K+ than by electrical stimulation, whereas moxonidine (in rabbit aorta a selective agonist at presynaptic alpha 2-adrenoceptors) exhibited similar potency in inhibiting the overflow evoked by both methods of stimulation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643914     DOI: 10.1007/bf00171042

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.

Authors:  V Lachaud-Pettiti; R A Podevin; Y Chrétien; A Parini
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

3.  Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery.

Authors:  G J Molderings; F Hentrich; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

4.  Non-adrenergic binding sites for the "alpha 2-antagonist" [3H]idazoxan in the rabbit urethral smooth muscle. Pharmacological and biochemical characterization.

Authors:  F Yablonsky; J P Dausse
Journal:  Biochem Pharmacol       Date:  1991-03-01       Impact factor: 5.858

5.  [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.

Authors:  M C Michel; O E Brodde; B Schnepel; J Behrendt; R Tschada; H J Motulsky; P A Insel
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

6.  Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist.

Authors:  R R Ruffolo; J E Waddell
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

7.  gamma-Aminobutyric acid and postganglionic sympathetic transmission in the pulmonary artery of the rabbit.

Authors:  K Starke; R Weitzell
Journal:  J Auton Pharmacol       Date:  1980-11

8.  An examination of the pre- and postsynaptic alpha-adrenoceptors involved in neuroeffector transmission in rabbit aorta and portal vein.

Authors:  J R Docherty; K Starke
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

9.  Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptors.

Authors:  G J Molderings; G Weissenborn; E Schlicker; J Likungu; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

10.  Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes.

Authors:  G J Molderings; D Moura; K Fink; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

View more
  9 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine.

Authors:  J Likungu; G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery.

Authors:  C González; S Regunathan; D J Reis; C Estrada
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.

Authors:  B G Taksande; N R Kotagale; K T Nakhate; P D Mali; D M Kokare; K Hirani; N K Subhedar; C T Chopde; R R Ugale
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

5.  Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.

Authors:  G J Molderings; K Schmidt; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

6.  Subclassification of presynaptic alpha 2-adrenoceptors: alpha 2A-autoreceptors in rabbit atria and kidney.

Authors:  N Limberger; L Funk; A U Trendelenburg; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

7.  Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.

Authors:  P V Escribá; R Alemany; M Sastre; G Olmos; A Ozaita; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

8.  Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction.

Authors:  Walter Raasch; Ulrich Schäfer; Fatimunnisa Qadri; Peter Dominiak
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 9.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.